These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 34066649)

  • 1. Crosstalk between Interleukin-1β and Type I Interferons Signaling in Autoinflammatory Diseases.
    Georgel P
    Cells; 2021 May; 10(5):. PubMed ID: 34066649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perception of self: distinguishing autoimmunity from autoinflammation.
    van Kempen TS; Wenink MH; Leijten EF; Radstake TR; Boes M
    Nat Rev Rheumatol; 2015 Aug; 11(8):483-92. PubMed ID: 25963881
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Type I interferonopathies. Systemic inflammatory diseases triggered by type I interferons].
    Günther C; Schmidt F; König N; Lee-Kirsch MA
    Z Rheumatol; 2016 Mar; 75(2):134-40. PubMed ID: 26744186
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autoinflammatory disorders, pain, and neural regulation of inflammation.
    Chen MC; Meckfessel MH
    Dermatol Clin; 2013 Jul; 31(3):461-70. PubMed ID: 23827248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The monogenic autoinflammatory diseases define new pathways in human innate immunity and inflammation.
    Manthiram K; Zhou Q; Aksentijevich I; Kastner DL
    Nat Immunol; 2017 Jul; 18(8):832-842. PubMed ID: 28722725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights from Mendelian Interferonopathies: Comparison of CANDLE, SAVI with AGS, Monogenic Lupus.
    Kim H; Sanchez GA; Goldbach-Mansky R
    J Mol Med (Berl); 2016 Oct; 94(10):1111-1127. PubMed ID: 27678529
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Type III Interferons (Lambda Interferons) in Rheumatic Autoimmune Diseases.
    Mora-Arias T; Amezcua-Guerra LM
    Arch Immunol Ther Exp (Warsz); 2020 Jan; 68(1):1. PubMed ID: 31915933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Role of Cutaneous Type I IFNs in Autoimmune and Autoinflammatory Diseases.
    Turnier JL; Kahlenberg JM
    J Immunol; 2020 Dec; 205(11):2941-2950. PubMed ID: 33229366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Update on Autoinflammatory Diseases: Interferonopathies.
    Davidson S; Steiner A; Harapas CR; Masters SL
    Curr Rheumatol Rep; 2018 May; 20(7):38. PubMed ID: 29846818
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Blocking interleukin-1β in acute and chronic autoinflammatory diseases.
    Dinarello CA
    J Intern Med; 2011 Jan; 269(1):16-28. PubMed ID: 21158974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A critical role for interleukin-1β in the progression of autoimmune diseases.
    Zhao R; Zhou H; Su SB
    Int Immunopharmacol; 2013 Nov; 17(3):658-69. PubMed ID: 24012439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human life within a narrow range: The lethal ups and downs of type I interferons.
    Crow YJ; Casanova JL
    Sci Immunol; 2024 Jul; 9(97):eadm8185. PubMed ID: 38968338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Interactions Between Autoinflammation and Type 2 Immunity: From Mechanistic Studies to Epidemiologic Associations.
    Sylvester M; Son A; Schwartz DM
    Front Immunol; 2022; 13():818039. PubMed ID: 35281022
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Monogenic autoinflammatory disorders: Conceptual overview, phenotype, and clinical approach.
    Nigrovic PA; Lee PY; Hoffman HM
    J Allergy Clin Immunol; 2020 Nov; 146(5):925-937. PubMed ID: 33160483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The receptor-type protein tyrosine phosphatase CD45 promotes onset and severity of IL-1β-mediated autoinflammatory osteomyelitis.
    Kralova J; Pavliuchenko N; Fabisik M; Ilievova K; Spoutil F; Prochazka J; Pokorna J; Sedlacek R; Brdicka T
    J Biol Chem; 2021 Oct; 297(4):101131. PubMed ID: 34461100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type I interferons protect from Toll-like receptor 9-associated liver injury and regulate IL-1 receptor antagonist in mice.
    Petrasek J; Dolganiuc A; Csak T; Kurt-Jones EA; Szabo G
    Gastroenterology; 2011 Feb; 140(2):697-708.e4. PubMed ID: 20727895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The emerging role of interleukin-1β in autoinflammatory diseases.
    Lane T; Lachmann HJ
    Curr Allergy Asthma Rep; 2011 Oct; 11(5):361-8. PubMed ID: 21728024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon lambda in inflammation and autoimmune rheumatic diseases.
    Goel RR; Kotenko SV; Kaplan MJ
    Nat Rev Rheumatol; 2021 Jun; 17(6):349-362. PubMed ID: 33907323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deregulated inflammasome signaling in disease.
    Lamkanfi M; Vande Walle L; Kanneganti TD
    Immunol Rev; 2011 Sep; 243(1):163-73. PubMed ID: 21884175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intracellular DNA recognition.
    Hornung V; Latz E
    Nat Rev Immunol; 2010 Feb; 10(2):123-30. PubMed ID: 20098460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.